We are live on ! Find out more
RVPH

REVIVA PHARMA HLDGS INC
RVPH

Delisted

RVPH was delisted on the 13th of May, 2026.

Back to rankings

42 hedge funds and large institutions have $14M invested in REVIVA PHARMA HLDGS INC in 2024 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 9

70% more call options, than puts

Call options by funds: $2.79M | Put options by funds: $1.65M

27% more funds holding

Funds holding: 33 → 42 (+9)

25% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 8

0.67% less ownership

Funds ownership: 1.5% → 0.83% (-0.67%)

6% less capital invested

Capital invested by funds: $14.9M → $14M (-$927K)

Holders
42
Holders Change
+9
Holders Change %
+27.27%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
10
Reduced
8
Closed
9
Calls
$2.79M
Puts
$1.65M
Net Calls
+$1.15M
Net Calls Change
+$858K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$500K
2
TCM
Tang Capital Management
California
+$237K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$193K
4
Ameriprise
Ameriprise
Minnesota
+$64.7K
5
EGM
Engineers Gate Manager
New York
+$48.1K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$2.54M
2
WP
Woodline Partners
California
-$986K
3
SSA
Schonfeld Strategic Advisors
New York
-$637K
4
PAMP
Polar Asset Management Partners
Ontario, Canada
-$223K
5
Focus Partners Wealth
Focus Partners Wealth
Massachusetts
-$141K
Name Holding Trade Value Shares
Change 		Change in
Stake
VPIM
26
Vanguard Personalized Indexing Management
California
$25.3K +$19.5K +699 New
Commonwealth Equity Services
27
Commonwealth Equity Services
Massachusetts
$23K +$780 +28 +5%
NWM
28
NRI Wealth Management
California
$22.4K +$17.2K +619 New
BCM
29
BluePointe Capital Management
California
$18.8K – – –
Northwestern Mutual Wealth Management
30
Northwestern Mutual Wealth Management
Wisconsin
$16.8K – – –
Morgan Stanley
31
Morgan Stanley
New York
$11.1K – – –
IA
32
IFP Advisors
Florida
$8.87K +$6.82K +245 New
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$3K +$2.09K +75 New
SWM
34
Spire Wealth Management
Virginia
$2.17K +$1.67K +60 New
GGI
35
Godsey & Gibb Inc
Virginia
$1.99K -$696 -25 -31%
AWM
36
Activest Wealth Management
Florida
$1.81K – – –
Jones Financial Companies
37
Jones Financial Companies
Missouri
$1.52K +$1.17K +42 New
Bank of America
38
Bank of America
North Carolina
$581 +$139 +5 +45%
TCM
39
Tradewinds Capital Management
Washington
$453 +$362 +13 New
JP Morgan Chase
40
JP Morgan Chase
New York
$425 +$334 +12 New
WAM
41
Wolverine Asset Management
Illinois
$220 -$4.79K -172 -97%
RS
42
R Squared
Hong Kong
$54 +$56 +2 New
WP
43
Woodline Partners
California
– -$986K -34,240 Closed
PAMP
44
Polar Asset Management Partners
Ontario, Canada
– -$223K -7,740 Closed
Group One Trading
45
Group One Trading
Illinois
– -$105K -3,779 Closed
VF
46
Virtu Financial
New York
– -$21K -713 Closed
TSS
47
Two Sigma Securities
New York
– -$20.1K -697 Closed
Citadel Advisors
48
Citadel Advisors
Florida
– -$18.8K -675 Closed
UBS Group
49
UBS Group
Switzerland
– -$3.33K -116 Closed
Deutsche Bank
50
Deutsche Bank
Germany
– -$2.88K -100 Closed
1
2
3

RVPH Hedge Fund Activity: Q4 2024 in Review

42 of the 7,599 institutional investors tracked by Wall St. Rank reported a position in REVIVA PHARMA HLDGS INC (RVPH) for Q4 2024, worth a combined $14M — down 6.2% from $14.9M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new RVPH positions and 9 closed out — a net gain of 9 holders — while 10 added to existing stakes and 8 trimmed.

The largest buyer was Vanguard Group, adding an estimated $500K. The largest seller was Armistice Capital, cutting an estimated $2.54M.

  • 42 institutional investors held REVIVA PHARMA HLDGS INC (RVPH) as of Q4 2024, up from 33 in Q3 2024.
  • Funds reported $14M of REVIVA PHARMA HLDGS INC stock for Q4 2024, down 6.2% quarter-over-quarter.
  • 18 funds opened new REVIVA PHARMA HLDGS INC positions in Q4 2024 and 9 closed out, a net change of +9 holders.
  • The largest REVIVA PHARMA HLDGS INC buyer in Q4 2024 was Vanguard Group, an estimated $500K added.
  • The largest REVIVA PHARMA HLDGS INC seller in Q4 2024 was Armistice Capital, an estimated $2.54M sold.

Based on aggregated 13F filings for Q4 2024.